Every skin flake, hair follicle, eyelash, and spit drop cast from your body contains instructions written in a chemical code, one that is unique to you.
According to a new study, technology has advanced to the point that it's now possible to sift scraps of human DNA out of the air, water, or soil and decipher personal details about the individuals who dropped them.
As useful as this might seem, the study's authors warn society might not be prepared for the consequences.
"Any time we make a technological advance, there are beneficial things that the technology can be used for and concerning things that the technology can be used for," says University of Florida zoologist David Duffy, who led a project that tested the limits of sequencing human DNA from the environment.
"These are issues we are trying to raise early so policy makers and society have time to develop regulations."
Earth's surface is dusted in discarded plant and animal cells and disintegrated microbes, spilling out what researchers refer to as environmental or 'e' DNA.
By amplifying the smallest scraps of eDNA and reading the sequences, researchers can accurately produce an ecological cast list of organisms present in any one habitat, all at speeds and costs that couldn't be achieved by field work.
What's more, those representative genetic samples can also deliver insights that no other process could accomplish on their own, such as informing researchers on the presence of diseases or the relationships between populations.
This is all well and good when zoologists are plucking long lost genes from ancient sediment, or fishing for signs of a mythological monster in Loch Ness. But in that genetic soup there are bound to be strands of material left by passing humans as well. And unlike Nessie, people tend to get a little funny about who snoops on their genetic secrets.
While older methods of sequencing have struggled to find meaningful human genetic sequences within eDNA samples, a process known as shotgun sequencing isn't quite so limited, as demonstrated by Duffy and his team in their recent investigation.
The research team took water and sand samples from near the Whitney Laboratory for Marine Bioscience and Sea Turtle Hospital at the University of Florida, and from environments along a river in Duffy's home country of Ireland. Among the sites they collected samples from was an isolated island and a mountain stream far from human habitation.
Referred to as human genetic bycatch (HGB), many of the chromosomal fragments they identified using the shotgun approach contained identifying information about their source.
Only the island and remote stream were free of human DNA, although traces of the research team's own genes could be extracted from their footprints in the isolated island's sand.
Air samples from the university's sea turtle hospital also contained eDNA that could be traced to staff, animals, and common animal viruses.
"We've been consistently surprised throughout this project at how much human DNA we find and the quality of that DNA," says Duffy. "In most cases the quality is almost equivalent to if you took a sample from a person."
It's easy to think of ways such highly detailed genetic assays using HGB might be applied in fields of epidemiology or population genetics. Yet the sources of the identifiable DNA in this experiment all consented to be involved in the study, in line with the ethics of published genetic research.
"It's standard in science to make these sequences publicly available. But that also means if you don't screen out human information, anyone can come along and harvest this information," says Duffy.
"That raises issues around consent. Do you need to get consent to take those samples? Or institute some controls to remove human information?"
As a forensics tool, the benefits are something of a doubled-edged sword, expanding on methods for tracing individuals to a scene of a crime.
Yet in light of the CSI effect, where the results of DNA testing is easily misinterpreted by a Hollywood-influenced judiciary, the legal consequences of HGB identification are also yet to be fully explored.
There is also the concern of how far public surveillance should extend in the name of security.
"To be sure, solving crime is a good thing," says Natalie Ram, a law expert from the University of Maryland who wasn't involved in the study.
"But exploiting involuntarily shed genetic information for investigative aims risks putting all of us under perpetual genetic surveillance."
We might imagine an authority maintaining an archive of DNA scraps that have drifted onto just about any crime scene, one few of us would feel comfortable being a part of.
It's far from the first time society has wrestled with the ethical and legal questions of genetic rights, of course. But the net collecting personal genetic information is clearly growing, prompting us to continue asking who should have the ultimate say over the unique code that describes us as individuals.
News
Using Cannabis Could Raise Your Stroke Risk by 37%, Massive Study Reveals
Large-scale evidence suggests cannabis, cocaine, and amphetamines may directly raise stroke risk, including in younger adults. As recreational drug use becomes increasingly common, researchers are uncovering evidence that its health consequences may extend far beyond [...]
Could Vitamin C Be the Secret to Keeping Your Brain Younger?
Lower vitamin C levels were linked to reduced brain volume and weaker neural connectivity in older adults, suggesting a potential connection between nutrition and brain health. Could a common vitamin help preserve the brain [...]
This Deadly Disease Was Wiping Out Humans 5,500 Years Ago
A new study suggests plague was already a deadly threat 5,500 years ago, striking small hunter-gatherer communities long before cities and agriculture emerged. For centuries, plague has been remembered as the disease that devastated [...]
China closing in but US leads in biotech quality, commercial reach, survey finds
SAN DIEGO, June 22 (Reuters) - China, which now conducts more clinical drug trials, opens new tab than the U.S., still lags in the quality and commercial reach of its biomedical science, according to a recent survey, opens new [...]
New method generates renewable supply of progenitor immune cells
In a paper published in Cell, a USC Stem Cell-led team reports a new way of generating a renewable and expandable supply of the progenitor cells that give rise to macrophages. These immune cells help [...]
Scientists Just Discovered a Cellular Survival System That Was Never Supposed To Exist
A surprising backup pathway allows cells to make a crucial amino acid when their primary machinery fails. For decades, biologists believed cells had only one way to access a molecule they cannot live without. New [...]
Artificial cells gain porous membranes, enabling lab reactions and drug release
Artificial cells created in the laboratory offer a wide range of potential applications. Until now, however, their membranes—unlike those of real cells—have been virtually impermeable. Researchers at the Max Planck Institute for Polymer Research, [...]
Popular Weight-Loss Drugs Like Ozempic Linked to Lower Breast Cancer Risk
Ozempic and similar weight-loss drugs were linked to a striking 30% reduction in breast cancer risk in a study of more than 110,000 women. Popular weight-loss and diabetes medications such as Ozempic, Wegovy, Mounjaro, [...]
Stanford Scientists Discover Explosive New Type of Immune Cell
Scientists studying the remarkable regenerative abilities of planarian flatworms have uncovered a previously unknown type of immune cell with an unusually destructive defense strategy. What if an immune cell could wipe out nearby threats [...]
Big Pharma-backed SonoThera sounds off with $125M series B for bubble-based genetic delivery
Bay Area biotech SonoThera is bubbling to a clinical boil after raising a $125 million series B with the backing of some of the biggest names in pharma. Vida Ventures led the raise, with the venture [...]
Joint initiative of 5 EU countries calls for ‘unified approach’ to pharma framework amid US drug pricing pressure
With drug pricing pressure building from the U.S., a healthcare-focused consortium of five European countries is calling for a “unified approach” to strengthen Europe’s pharmaceutical framework and access to innovative medicines. Belgium, the Netherlands, [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Molecular Manufacturing: The Future of Nanomedicine – New book from NanoappsMedical Inc.
This book explores the revolutionary potential of atomically precise manufacturing technologies to transform global healthcare, as well as practically every other sector across society. This forward-thinking volume examines how envisaged Factory@Home systems might enable the cost-effective [...]
NanoMedical Brain/Cloud Interface – Explorations and Implications. A new book from Frank Boehm
New book from Frank Boehm, NanoappsMedical Inc Founder: This book explores the future hypothetical possibility that the cerebral cortex of the human brain might be seamlessly, safely, and securely connected with the Cloud via [...]
New book from Nanoappsmedical Inc. – Global Health Care Equivalency
A new book by Frank Boehm, NanoappsMedical Inc. Founder. This groundbreaking volume explores the vision of a Global Health Care Equivalency (GHCE) system powered by artificial intelligence and quantum computing technologies, operating on secure [...]
UCLA Scientists Uncover a “Hidden Weakness” in Some of the World’s Deadliest Cancers
A new study has uncovered an unexpected vulnerability in some of the deadliest cancers. Researchers at UCLA have identified a previously hidden weakness in some of the most aggressive cancers, pointing to a possible new way [...]















